Cart
sales@molnova.com
A66
CAS No. 1166227-08-2
A66( A 66 | A-66 )
Catalog No. M10568 CAS No. 1166227-08-2
A66 (p110α inhibitor A66) is a potent, highly specific p110α inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 42 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 114 | In Stock |
|
| 25MG | 221 | In Stock |
|
| 50MG | 389 | In Stock |
|
| 100MG | 575 | In Stock |
|
| 500MG | 1197 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameA66
-
NoteResearch use only, not for human use.
-
Brief DescriptionA66 (p110α inhibitor A66) is a potent, highly specific p110α inhibitor.
-
DescriptionA66 (p110α inhibitor A66) is a potent, highly specific p110α inhibitor with IC50 of 32, 30 and 43 nM for wt p110α, p110α E545K and p110α H1047R, respectively; displays little to no activity against p110β/γ/δ (IC50>3,000 nM), as well as class-III PI3Ks, mTOR, DNA-PK, and PI4Kα/β; induces reduction in focus formation CEF by the highly transforming iSH2 mutants KS459delN, DKRMNS560del, and K379E, blocks PI3K signalling and tumour growth in certain cell types.
-
In Vitro——
-
In Vivo——
-
SynonymsA 66 | A-66
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
Recptorp110α|p110γ|p110δ|PI3Kβ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1166227-08-2
-
Formula Weight393.52
-
Molecular FormulaC17H23N5O2S2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(N1[C@H](C(N)=O)CCC1)NC2=NC(C)=C(C3=CSC(C(C)(C)C)=N3)S2
-
Chemical Name1,2-Pyrrolidinedicarboxamide, N1-[2-(1,1-dimethylethyl)-4'-methyl[4,5'-bithiazol]-2'-yl]-, (2S)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jamieson S, et al. Biochem J. 2011 Aug 15;438(1):53-62.
2. Sun M, et al. Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15547-52.
3. Weigelt B, et al. Clin Cancer Res. 2013 Jul 1;19(13):3533-44.
molnova catalog
related products
-
GSK-2636771
GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.
-
PI-3065
A potent inhibitor of PI3K p110δ with IC50/Ki values of 5/1.5 nM respectively.
-
STX-478
STX-478 is an orally active and selective PI3Kα inhibitor that penetrates the blood-brain barrier and has anticancer activity to inhibit tumor growth.STX-478 is indicated for the study of breast cancer and other cancers.
